REPLY: The Assessment Approach of Frailty May Influence Its Prognostic Impact Amidst Clinical Trials

J Am Geriatr Soc. 2025 Jul 4. doi: 10.1111/jgs.19598. Online ahead of print.

Tu N Nguyen^{1

2}, Jie Yu^{3

4

5}, Vlado Perkovic³, Clare Arnott^{2

3

6}, Richard I Lindley^{1

2}

¹ The George Institute for Global Health, Sydney, New South Wales, Australia.
² Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
³ Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
⁴ Cardiovascular Department, John Hunter Hospital, Newcastle, New South Wales, Australia.
⁵ Hunter Medical Research Institute, University of Newcastle, Newcastle, New South Wales, Australia.
⁶ Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

No abstract available

Keywords: diabetes mellitus; frailty; frailty assessment; sodium‐glucose cotransporter 2 inhibitor.

Publication types